The Global Summit of Biopharma entitled 'New targets, new modalities and New Hopes' will take place from Wednesday 11 May to Friday 13 May, 2022 in Tokyo, Japan. It provides an intensive comprehensive program focusing on new targets discovery, design of new modalities, cutting-edge technologies, new discovery chemistry, innovative process development, smart bio-drug delivery systems and new biosimilars.
![]() |
Dr. Xiaodan Mei President BIT Group |
![]() |
Dr. John Xu SVP, USA Abpro |
![]() |
Prof. Shibo Jiang Director, Institute of Medical Microbiology, Fudan University, China Title: R&D of Broad-spectral Antivirals |
![]() |
Dr. Frank Li Founder and CEO, BLA Regulatory, USA |
![]() |
Dr. Ei-ichi Negishi, 2010 Nobel Prize in Chemistry H. C. Brown Distinguished Professor of Chemistry Purdue University |
![]() |
Dr. Ada E. Yonath, 2009 Nobel Prize Laureate in Chemistry Director & Professor Weizmann Institute of Science Israel |
![]() |
Dr. Arieh Warshel, 2010 Nobel Prize in Chemistry Distinguished Professor University of Southern California USA |
![]() |
Dr. Maode Lai, Academician of Nationale Akademie der Wissenschafte President China Pharmaceutical University China |
![]() |
Matthias von Herrath, Vice President, Novo Nordisk USA |
![]() |
Dr. Gilles Courtemanche, Associate Director, Antimicrobials Unit, BIOASTER, France |
![]() |
Dr. Mingqiang Zhang, Vice President Amgen BioPharmaceutical Co., Ltd. China |
![]() |
Dr. Litao Zhang, Vice President, Bristol-Myers Squibb USA |
![]() |
Joseph Donahue, Managing Director Accenture USA |
![]() |
Dr. Kenneth G. Faulkner, Vice President, PAREXEL Informatics USA |
![]() |
Dr. Daryl C. Drummond, Senior Vice President & Head of Research Merrimack Pharmaceuticals USA |
![]() |
Dr. Henrietta Ukwu, Senior Vice President & Global Head, Global Quality & Global Regulatory Affairs, Otsuka Pharmaceutica USA |
![]() |
Dr. Lucas P.J.J. Noldus, Founder & CEO, Noldus Information Technology bv, the Netherlands |
![]() |
Michael Gamlen, Chief Scientific Officer Gamlen Tableting Ltd UK |
![]() |
Dr. Loui Madakamutil, Senior Vice President Nektar Therapeutics USA |
![]() |
Dr. Jan Hoflack, Chief Scientific and Operational Officer, Oncodesign SA France |
![]() |
Dr. David C. Bunton, Chief Executive Officer REPROCELL Europe Ltd., UK |
![]() |
Dr. Kurt Herrenknecht, Founder & Managing Director SciArcum Biotech Consulting Germany |
![]() |
Dr. Hankoo Lee, Honorary Chairman Daehwa Pharmaceutical Co. South Korea |
![]() |
Dr. Yoshinori Ikeura Chief Executive Officer Axcelead Drug Discovery Partners, Inc. Japan |
![]() |
Zhuo Li, General Manager Nano Temper Chinanewspeaker/20.jpg |
![]() |
Gregory L. Verdine, Harvard University and Harvard Medical School USA |
![]() |
Dr. David A. Horne, Vice Provost Beckman Research Institute USA |
![]() |
Pavel Hobza, Distinguish Chair Academy of Sciences of the Czech Republic Czech Republic |
GSB-2022 provides an ideal platform to showcase your novel technologies and products in the Venetian Tokyo Resort Hotel. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at GSB-2022
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition
Hall
![]() ![]() |
Exhibition Date: |
© 2003-2022 All rights reserved by BIT Group Global Ltd. |